Literature DB >> 16446055

A technique for adaptive image-guided helical tomotherapy for lung cancer.

Chester R Ramsey1, Katja M Langen, Patrick A Kupelian, Daniel D Scaperoth, Sanford L Meeks, Stephen L Mahan, Rebecca M Seibert.   

Abstract

PURPOSE: The gross tumor volume (GTV) for many lung cancer patients can decrease during the course of radiation therapy. As the tumor reduces in size during treatment, the margin added around the GTV effectively becomes larger, which can result in the excessive irradiation of normal lung tissue. The specific goal of this study is to evaluate the feasibility of using image-guided adaptive radiation therapy to adjust the planning target volume weekly based on the previous week's CT image sets that were used for image-guided patient setup. METHODS AND MATERIALS: Megavoltage computed tomography (MVCT) images of the GTV were acquired daily on a helical tomotherapy system. These images were used to position the patient and to measure reduction in GTV volume. A planning study was conducted to determine the amount of lung-sparing that could have been achieved if adaptive therapy had been used. Treatment plans were created in which the target volumes were reduced after tumor reduction was measured.
RESULTS: A total of 158 MVCT imaging sessions were performed on 7 lung patients. The GTV was reduced by 60-80% during the course of treatment. The tumor reduction in the first 60 days of treatment can be modeled using the second-order polynomial R = 0.0002t(2) - 0.0219t + 1.0, where R is the percent reduction in GTV, and t is the number of elapsed days. Based on these treatment planning studies, the absolute volume of ipsilateral lung receiving 20 Gy can be reduced between 17% and 23% (21% mean) by adapting the treatment delivery. The benefits of adaptive therapy are the greatest for tumor volumes > or =25 cm3 and are directly dependent on GTV reduction during treatment.
CONCLUSIONS: Megavoltage CT-based image guidance can be used to position lung cancer patients daily. This has the potential to decrease margins associated with daily setup error. Furthermore, the adaptive therapy technique described in this article can decrease the volume of healthy lung tissue receiving above 20 Gy. However, further study is needed to determine whether adaptive therapy could result in the underdosing of microscopic extension.

Entities:  

Mesh:

Year:  2006        PMID: 16446055     DOI: 10.1016/j.ijrobp.2005.11.012

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  20 in total

1.  Combining advanced radiotherapy technologies to maximize safety and tumor control probability in stage III non-small cell lung cancer.

Authors:  M Guckenberger; A Kavanagh; M Partridge
Journal:  Strahlenther Onkol       Date:  2012-08-31       Impact factor: 3.621

2.  Investigation into image quality and dose for different patient geometries with multiple cone-beam CT systems.

Authors:  Stephen J Gardner; Matthew T Studenski; Tawfik Giaddui; Yunfeng Cui; James Galvin; Yan Yu; Ying Xiao
Journal:  Med Phys       Date:  2014-03       Impact factor: 4.071

3.  Three-dimensional patient setup errors at different treatment sites measured by the Tomotherapy megavoltage CT.

Authors:  S K Hui; E Lusczek; T DeFor; K Dusenbery; S Levitt
Journal:  Strahlenther Onkol       Date:  2012-03-09       Impact factor: 3.621

4.  Evaluation on lung cancer patients' adaptive planning of TomoTherapy utilising radiobiological measures and Planned Adaptive module.

Authors:  Fan-Chi Su; Chengyu Shi; Panayiotis Mavroidis; Prema Rassiah-Szegedi; Niko Papanikolaou
Journal:  J Radiother Pract       Date:  2009-01-01

5.  Postoperative radiotherapy is associated with better survival in non-small cell lung cancer with involved N2 lymph nodes: results of an analysis of the National Cancer Data Base.

Authors:  John L Mikell; Theresa W Gillespie; William A Hall; Dana C Nickleach; Yuan Liu; Joseph Lipscomb; Suresh S Ramalingam; Raj S Rajpara; Seth D Force; Felix G Fernandez; Taofeek K Owonikoko; Rathi N Pillai; Fadlo R Khuri; Walter J Curran; Kristin A Higgins
Journal:  J Thorac Oncol       Date:  2015-03       Impact factor: 15.609

Review 6.  Radiomics in precision medicine for lung cancer.

Authors:  Julie Constanzo; Lise Wei; Huan-Hsin Tseng; Issam El Naqa
Journal:  Transl Lung Cancer Res       Date:  2017-12

7.  Dose-guided radiotherapy for lung tumors.

Authors:  Angelo Piermattei; Andrea Fidanzio; Savino Cilla; Francesca Greco; Luigi Azario; Domenico Sabatino; Mattia Grusio; Mariella Cozzolino; Vincenzo Fusco
Journal:  Med Biol Eng Comput       Date:  2009-12-10       Impact factor: 2.602

8.  Adaptive radiation for lung cancer.

Authors:  Daniel R Gomez; Joe Y Chang
Journal:  J Oncol       Date:  2010-08-04       Impact factor: 4.375

9.  Dosimetric verification of lung cancer treatment using the CBCTs estimated from limited-angle on-board projections.

Authors:  You Zhang; Fang-Fang Yin; Lei Ren
Journal:  Med Phys       Date:  2015-08       Impact factor: 4.071

10.  Benefits of adaptive radiation therapy in lung cancer as a function of replanning frequency.

Authors:  Christian Dial; Elisabeth Weiss; Jeffrey V Siebers; Geoffrey D Hugo
Journal:  Med Phys       Date:  2016-04       Impact factor: 4.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.